Clinical Trials on Benign Prostatic Hypertrophy With Outflow Obstruction in Taiwan

Total 2 results

Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Taiwan
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital and other collaborators

Recruiting

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Aortic Stenosis | Aortic Stenosis With Bicuspid Valve

China

3

Subscribe